Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Entrada Therapeutics (TRDA) Current Taxes: 2023-2025

Historic Current Taxes for Entrada Therapeutics (TRDA) over the last 1 years, with Sep 2025 value amounting to $620,000.

  • Entrada Therapeutics' Current Taxes fell 72.46% to $620,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $620,000, marking a year-over-year decrease of 72.46%. This contributed to the annual value of $667,000 for FY2024, which is 83.42% down from last year.
  • Latest data reveals that Entrada Therapeutics reported Current Taxes of $620,000 as of Q3 2025, which was down 22.69% from $802,000 recorded in Q1 2025.
  • Over the past 5 years, Entrada Therapeutics' Current Taxes peaked at $7.4 million during Q2 2023, and registered a low of $620,000 during Q3 2025.
  • For the 3-year period, Entrada Therapeutics' Current Taxes averaged around $3.2 million, with its median value being $3.1 million (2023).
  • Data for Entrada Therapeutics' Current Taxes shows a maximum YoY crashed of 86.30% (in 2025) over the last 5 years.
  • Entrada Therapeutics' Current Taxes (Quarterly) stood at $4.0 million in 2023, then plummeted by 83.42% to $667,000 in 2024, then crashed by 72.46% to $620,000 in 2025.
  • Its last three reported values are $620,000 in Q3 2025, $802,000 for Q1 2025, and $667,000 during Q4 2024.